Investors
As an emerging biotechnology company, Bertech is seeking collaboration and licensing opportunities with other biotech and pharmaceutical companies as an integral part of its product development strategy.
Bertech is open to discussing any licensing or collaboration opportunities for our products, as well as potential partnerships that may be of mutual interest.
Please contact us for more information.
Latest News >
- March 11, 2020 — Bertech’s Pivotal Trial Validates Blood Test for Colorectal Cancer
- February 26, 2013 — Dr. David Dureck joins Bertech Pharma’s Scientific Board of Advisors
- September 06, 2012 — Dr. David Evans and Dr. Randall Johnston join Bertech Pharma’s Scientific Board of Advisors
- More...